| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2023 | CDNA Caredx, Inc. | Maag Peter84 | Director | Sell | 5,000 | $17.17 | $85,829.50 | -1.6% | -51.6% | -50.5% | |
| Feb 2, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 25,000 | $27.48 | $686,928.07 | -1.6% | -19.6% | -17.8% | |
| Feb 2, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,819 | $17.15 | $48,346.63 | -0.2% | -51.6% | -50.5% | |
| Feb 1, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,384 | $27.11 | $227,265.09 | -1.7% | -19.8% | -14.0% | |
| Feb 1, 2023 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 1,000 | $67.93 | $67,930.00 | -1.2% | -7.4% | -6.1% | |
| Feb 1, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 103,023 | $42.47 | $4,375,037.82 | -18.8% | +14.4% | +55.1% | |
| Jan 31, 2023 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 10,000 | $2.41 | $24,100.00 | - | -30.8% | -16.7% | |
| Jan 31, 2023 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 562 | $2.20 | $1,236.40 | -0.4% | -1.3% | -43.0% | |
| Jan 31, 2023 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 767 | $2.20 | $1,687.40 | -0.4% | -1.3% | -43.0% | |
| Jan 31, 2023 | WGS Genedx Holdings Corp. | Icahn School Of Medicine At Mount Sinai | 10% Owner | Buy | 28,571,428 | $0.35 | $9,999,999.80 | +30.2% | -41.0% | -72.5% | |
| Jan 31, 2023 | WGS Genedx Holdings Corp. | Casdin Eli50 | Director, 10% Owner | Buy | 85,714,285 | $0.35 | $29,999,999.75 | +521.5% | -41.0% | -72.5% | |
| Jan 27, 2023 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 50,000 | $2.51 | $125,430.00 | +0.2% | -30.4% | -21.2% | |
| Jan 26, 2023 | WGS Genedx Holdings Corp. | Opko Health, Inc. | 10% Owner | Buy | 14,285,714 | $0.35 | $4,999,999.90 | +17.9% | -25.0% | -72.8% | |
| Jan 26, 2023 | WGS Genedx Holdings Corp. | White Karen Ann77 | Chief People Officer | Sell | 2,241 | $0.36 | $810.12 | -10.0% | -25.0% | -72.8% | |
| Jan 25, 2023 | DHR Danaher Corp /de/ | Stevens Raymond C | - | Sell | 8,410 | $264.27 | $2,222,513.76 | -25.0% | -11.8% | -13.5% | |
| Jan 23, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 5,370 | $41.56 | $223,175.59 | -4.9% | +22.6% | +53.9% | |
| Jan 23, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 51 | $41.56 | $2,119.54 | - | +22.6% | +53.9% | |
| Jan 23, 2023 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 4,256 | $41.56 | $176,878.08 | -50.2% | +22.6% | +53.9% | |
| Jan 23, 2023 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 2,273 | $41.56 | $94,465.20 | -2.2% | +22.6% | +53.9% | |
| Jan 23, 2023 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 2,387 | $41.56 | $99,203.00 | -1.6% | +22.6% | +53.9% | |
| Jan 20, 2023 | PRPO Precipio, Inc. | Sandberg Richard A74 | Director | Buy | 20,000 | $0.78 | $15,530.00 | +95.9% | -22.0% | -58.0% | |
| Jan 20, 2023 | MYGN Myriad Genetics Inc | Riggsbee Richard Bryan51 | Chief Financial Officer | Sell | 9,400 | $20.04 | $188,386.34 | -2.5% | +7.5% | -0.2% | |
| Jan 20, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 6,292 | $0.38 | $2,416.76 | -5.3% | -23.8% | -75.0% | |
| Jan 18, 2023 | MYGN Myriad Genetics Inc | Riggsbee Richard Bryan51 | Chief Financial Officer | Sell | 600 | $20.01 | $12,006.00 | -0.2% | +10.3% | +2.8% | |
| Jan 17, 2023 | VCYT Veracyte, Inc. | Anderson Bonnie H72 | Director | Sell | 34,000 | $26.35 | $895,837.52 | -20.7% | -14.0% | -4.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.